Cheers hoofa. I don't mind any sort of investor or trader as they are genuine in their intent. I appreciate any genuine input and a fair amount of frivolity
Thanks for the graph greg . I can't with my simple systems but with your data package can you do one with just the VWAP for each day? Quite interesting to see what the real volumes went through at not just the open and close that are easily manipulated.
I feel things will happen a bit slower even with extra cash on board and they have one go at showing they can actually speed up entry into the market with their products and keep margins and increase net margins with efficiencies. I want RHT getting the benefit of volume not just their partner. It takes along time to get penetration even when you are finally regarded as the gold standard but people will also understand that once volume is achieved it is very sticky until a replacement product comes along that insurers are happy to use. Previous increases in volume came from trials where specific data and a means of measuring it was required and that will slowly translate into specialists but we all have to remember that there is a whole high margin biopsy industry set up, approved that will fight dirty to keep market share. We also need to ensure we have the right staff to drive growth and I am pleased with our partner as long as they want to drive our product and if not RHT needs to do it or put a cracker up their date. Every day another new product has the chance of encroaching on our market sector so the sooner we can get dominance in each niche the harder the entry and profitability of any other technology becomes to develop let alone make profitable. RHt need to get off their dates now and put in a huge push in business not just science
RHT Price at posting:
4.9¢ Sentiment: None Disclosure: Held
